knowcompounds(4S)-4-hydroxy-L-isoleucine
Specimen compound
(4S)- 4- hydroxy- L- isoleucine
4-Hydroxyisoleucine, the amino acid of fenugreek seed, sold as a fenugreek extract standardised to it. A trial of a whole fenugreek seed or extract not stated as standardised to it is filed under Trigonella foenum-graecum.
Description on record
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 0
- Limited
- 0
- Very limited
- 0
- Insufficient
- 7
(4S)-4-hydroxy-L-isoleucine
Most findings
- HDL cholesterol×2
- Body mass×1
- Interleukin-6 concentration×1
- LDL cholesterol×1
- Total cholesterol (TC)×1
- Tumour necrosis factor alpha concentration×1
36 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
- HDL cholesterol
- Body mass
- Interleukin-6 concentration
- LDL cholesterol
- Total cholesterol (TC)
- Tumour necrosis factor alpha concentration
02 · findings
What (4S)-4-hydroxy-L-isoleucine moved, and by how much
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
7 shown
- HDL cholesterolMoved: raisesEvidence: Insufficientreplicated ×1Paper: PMID 201408042010
- Who
- C57BL/KsJ-db/db mice, a model of type II diabetes
- Dose studied
- 4-hydroxyisoleucine 50 mg/kg orally
4-Hydroxyisoleucine, when given orally to these mice at 50 mg kg(-1) dose level, significantly (p < 0.05) declined their elevated blood glucose, plasma insulin, triglycerides, total cholesterol, low-density lipoprotein-cholesterol levels and raised their declined plasma high-density lipoprotein-cholesterol level.”
Quoted verbatim from Antihyperglycaemic effect of an unusual amino acid (4-hydroxyisoleucine) in C57BL/KsJ-db/db mice.animal · not in humansPermalink - Body massMoved: lowersEvidence: InsufficientPaper: PMID 409173562025
- Who
- male C57BL/6 mice with high-fat-diet-induced obesity (10 weeks HFD), high-fat diet continued in both arms
- Dose studied
- 4-hydroxyisoleucine 200 mg/kg/day by intraperitoneal injection in 0.3 ml saline per 30 g body weight for six weeks; control HFD mice received saline injections
Consistent with previous reports, we observed that 4-HIL treatment significantly reduced the body weight of mice in the HFD group compared to HFD mice without treatment.”
Quoted verbatim from Potential role of 4-hydroxyisoleucine in enhancing fertility in male mice with diet-induced obesity.animal · not in humans · 6 weeksPermalink - HDL cholesterolMoved: raisesEvidence: Insufficientreplicated ×1Paper: PMID 186801212009
- Who
- streptozotocin-induced diabetic rats (described as a type 2 diabetes model)
- Dose studied
- not reported
In diabetic rats, treatment with 4-hydroxyisoleucine did not affect glucose or liver damage markers, but did improve HDL-cholesterol levels (31% increase, p < 0.05).”
Quoted verbatim from The effect of fenugreek 4-hydroxyisoleucine on liver function biomarkers and glucose in diabetic and fructose-fed rats.animal · not in humansPermalink - LDL cholesterolMoved: lowersEvidence: InsufficientPaper: PMID 201408042010
- Who
- C57BL/KsJ-db/db mice, a model of type II diabetes
- Dose studied
- 4-hydroxyisoleucine 50 mg/kg orally
4-Hydroxyisoleucine, when given orally to these mice at 50 mg kg(-1) dose level, significantly (p < 0.05) declined their elevated blood glucose, plasma insulin, triglycerides, total cholesterol, low-density lipoprotein-cholesterol levels and raised their declined plasma high-density lipoprotein-cholesterol level.”
Quoted verbatim from Antihyperglycaemic effect of an unusual amino acid (4-hydroxyisoleucine) in C57BL/KsJ-db/db mice.animal · not in humansPermalink - Total cholesterol (TC)Moved: lowersEvidence: InsufficientPaper: PMID 201408042010
- Who
- C57BL/KsJ-db/db mice, a model of type II diabetes
- Dose studied
- 4-hydroxyisoleucine 50 mg/kg orally
4-Hydroxyisoleucine, when given orally to these mice at 50 mg kg(-1) dose level, significantly (p < 0.05) declined their elevated blood glucose, plasma insulin, triglycerides, total cholesterol, low-density lipoprotein-cholesterol levels and raised their declined plasma high-density lipoprotein-cholesterol level.”
Quoted verbatim from Antihyperglycaemic effect of an unusual amino acid (4-hydroxyisoleucine) in C57BL/KsJ-db/db mice.animal · not in humansPermalink - Interleukin-6 concentrationMoved: lowersEvidence: InsufficientPaper: PMID 409173562025
- Who
- male C57BL/6 mice with high-fat-diet-induced obesity, high-fat diet continued in both arms
- Dose studied
- 4-hydroxyisoleucine 200 mg/kg/day by intraperitoneal injection for six weeks; control HFD mice received saline injections
In addition, inflammatory markers, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFα), were assessed, and their serum and testis concentrations were found to be reduced in 4-HIL treated mice compared to those in HFD mice (Supplementary Figures S2C, D).”
Quoted verbatim from Potential role of 4-hydroxyisoleucine in enhancing fertility in male mice with diet-induced obesity.animal · not in humans · 6 weeksPermalink - Tumour necrosis factor alpha concentrationMoved: lowersEvidence: InsufficientPaper: PMID 409173562025
- Who
- male C57BL/6 mice with high-fat-diet-induced obesity, high-fat diet continued in both arms
- Dose studied
- 4-hydroxyisoleucine 200 mg/kg/day by intraperitoneal injection for six weeks; control HFD mice received saline injections
In addition, inflammatory markers, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFα), were assessed, and their serum and testis concentrations were found to be reduced in 4-HIL treated mice compared to those in HFD mice (Supplementary Figures S2C, D).”
Quoted verbatim from Potential role of 4-hydroxyisoleucine in enhancing fertility in male mice with diet-induced obesity.animal · not in humans · 6 weeksPermalink
No row matches these filters.
No dose is advised.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
03 · on the label · 11 products
Labelled products
Source: NIH DSLD · Ingredient: (4S)-4-hydroxy-L-isoleucine · 11 products · Declared amount per serving: 66–100 mg
2 labels state an amount9 do not
- EvogenGlycoJect Unflavoredamount not statedper 26 gDSLD:31052
- EvogenGlycoJect Watermelonamount not statedper 27 gDSLD:31050
- Gaspari NutritionSuperPump 250 Blue Raspberry4-Hydroxyisoleucine, Fenugreek Extract, from Fenugreek seed extract, seedamount not statedper 6.5 gDSLD:80711
- Gaspari NutritionSuperPump 250 Boardwalk Cotton Candy4-Hydroxyisoleucine, Fenugreek Extract, from Fenugreek seed extract, seedamount not statedper 6.5 gDSLD:80661
- Gaspari NutritionSuperPump 250 Country Life Pink Lemonade4-Hydroxyisoleucine, Fenugreek Extract, from Fenugreek seed extract, seedamount not statedper 6.5 gDSLD:80699
- Gaspari NutritionSuperPump 250 Country Life Pink Lemonade4-Hydroxyisoleucine, Fenugreek Extract, from Fenugreek seed extract, seedamount not statedper 6.5 gDSLD:80746
- Gaspari NutritionSuperPump 250 Rainbow Italian Ice4-Hydroxyisoleucine, Fenugreek Extract, from Fenugreek seed extract, seedamount not statedper 6.5 gDSLD:80706
- Gaspari NutritionSuperPump 250 Rainbow Italian Ice4-Hydroxyisoleucine, Fenugreek Extract, from Fenugreek seed extract, seedamount not statedper 6.5 gDSLD:80756
- Gaspari NutritionSuperPump 250 Strawberry Kiwi4-Hydroxyisoleucine, Fenugreek Extract, from Fenugreek seed extract, seedamount not statedper 6.5 gDSLD:80759
- Musclegen ResearchFreak Mutant Lime66 mgper 1 scoopDSLD:213489
- PEScienceMass-NP4-Hydroxyisoleucine, standardized from Fenugreek seed extract, seed100 mgper 3 capsulesDSLD:230704
Label record: NIH Office of Dietary Supplements · CC0
04 · the record
Sources
20
papers screened for (4S)-4-hydroxy-L-isoleucine
- admitted
- 3
- read and discarded
- 7
- not read yet
- 10
- Documented interactions
- None reported
Sources cited
3 papers · 7 findings